Abstract
Background Globally, both human papillomavirus (HPV) infection and osteoporosis (OP) are more prevalent in women than in men. It remains unclear whether HPV has an impact on bone health.
Methods This case-control study was based on data from the National Health and Nutrition Examination Survey (NHANES). Comparable datasets were created via the nearest neighbor propensity score matching (PSM) method (1:2). The Welch two-sample t test was used to analyze the association between HPV infection and bone mineral density (BMD). Restricted cubic spline (RCS) and Kendall’s tau-b tests were used to explore the effect of HPV infection type on BMD.
Results BMDs in the legs and lumbar spine were lower in subjects infected with HPV than in uninfected subjects. RCS analysis showed that the larger the number of cooccurring HPV types in a woman, the lower the BMD was. In addition, four HPV types were negatively associated with leg BMD, and 14 HPV types were negatively associated with lumbar spine BMD. HPV types 53, 59, and 89 had effects on both leg and lumbar spine BMDs.
Conclusions HPV infection was associated with a decrease in BMD. Appropriately designed trials can help determine whether interventions to prevent HPV infection will have a protective effect on BMD.
Funding This research was not supported by any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was not supported by any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Shandong university
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.
